The growth inhibition effect seen in PHGDH-amplified breast cancer cells, together with increasing evidence of the prevalence of PHGDH expression in certain cancer types, makes the design of a PHGDH inhibitor highly desirable to allow for further target validation using a chemical probe. The gene discussed is PHGDH; the disease is breast cancer.